Internal Medicine, Hematology & Oncology · Chattanooga, TN
NPI
1487603817
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
605 Glenwood Dr, Suite 200
Chattanooga, TN, 37404
Phone (423) 698-1844
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
134,736 services
Medicare patients, 2024
680
Average age 75
Drug cost, 2024
$6.8M
2,840 prescriptions
Company payments, 2025
$894
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Derek W Holland was code J9144 (injection, daratumumab, 10 mg and hyaluronidase-fihj), 22,860 times for 15 patients. In total Derek W Holland billed 134,736 services in 166 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 22,860 | 15 | $39.01 | $892K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 13,500 | 12 | $0.86 | $12K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,200 | 11 | $44.49 | $320K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 6,420 | 13 | $2.34 | $15K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,000 | 34 | $16.18 | $65K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,322 | 51 | $0.09 | $207 |
| 85025 Blood Count | Office | 2,238 | 468 | $7.55 | $17K |
| 36415 Venipuncture Blood Collection | Office | 1,859 | 435 | $8.59 | $16K |
| 80053 Clinical Chemistry | Office | 1,763 | 422 | $10.31 | $18K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 840 | 33 | $0.25 | $212 |
| 99214 Office E&M - Established | Office | 680 | 275 | $86.42 | $59K |
| 82784 Immunoassay | Office | 553 | 39 | $9.11 | $5,040 |
| 99213 Office E&M - Established | Office | 469 | 280 | $59.02 | $28K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 457 | 75 | $70.14 | $32K |
| 83521 Immunoassay | Office | 402 | 46 | $16.93 | $6,804 |
By year: 2022 $2.6M for 207,462 services; 2023 $3.7M for 230,884 services; 2024 $3.2M for 134,736 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,238 | 468 | $7.55 | $17K |
| 36415 Venipuncture Blood Collection | 1,859 | 435 | $8.59 | $16K |
| 80053 Clinical Chemistry | 1,763 | 422 | $10.31 | $18K |
| 82784 Immunoassay | 553 | 39 | $9.11 | $5,040 |
| 83521 Immunoassay | 402 | 46 | $16.93 | $6,804 |
| 83615 Clinical Chemistry | 342 | 98 | $5.89 | $2,014 |
| 82728 Clinical Chemistry | 309 | 157 | $13.25 | $4,095 |
| 83540 Clinical Chemistry | 306 | 158 | $6.29 | $1,924 |
| 83550 Clinical Chemistry | 303 | 156 | $8.50 | $2,576 |
| 84165 Clinical Chemistry | 212 | 57 | $10.50 | $2,225 |
Medicare prescription drug claims, 2024
In 2024, the drug Derek W Holland prescribed most often to Medicare patients was Ondansetron Odt (Ondansetron), with 153 prescriptions and refills. In total Derek W Holland wrote 2,840 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | 153 | 153 | 73 | $3,403 |
| Acyclovir Generic | 128 | 182 | 29 | $1,899 |
| Dexamethasone Generic | 115 | 122 | 37 | $1,781 |
| Prednisone Generic | 95 | 109 | 33 | $433 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 90 | 90 | 40 | $1,711 |
| Abiraterone Acetate Generic | 71 | 73 | Under 11 | $94K |
| Calquence Acalabrutinib Maleate | 65 | 65 | Under 11 | $785K |
| Exemestane Generic | 64 | 90 | 11 | $8,387 |
| Prochlorperazine Maleate Generic | 62 | 62 | 44 | $679 |
| Potassium Chloride Generic | 60 | 74 | 21 | $449 |
| Oxycodone Hcl Generic | 59 | 59 | 28 | $1,899 |
| Eliquis Apixaban | 58 | 88 | 23 | $49K |
| Pomalyst Pomalidomide | 58 | 58 | Under 11 | $1.2M |
| Anastrozole Generic | 52 | 91 | 14 | $1,060 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 51 | 51 | 29 | $1,606 |
Brand drugs: - claims; generic drugs: 2,104 claims; opioid claims: 281.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Derek W Holland $894 ($894 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novartis Pharmaceuticals Corporation with $138.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $138 |
| Kite Pharma, Inc. GILD | 1 | $111 |
| Gilead Sciences, Inc. GILD | 4 | $104 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $61.56 |
| Merck Sharp & Dohme LLC MRK | 2 | $59.46 |
| Abbvie Inc. ABBV | 2 | $42.97 |
| Pfizer Inc. PFE | 2 | $39.09 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $33.33 |
| Daiichi Sankyo Inc. 4568.T | 1 | $29.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.